Published by Benjamin Chiou on 21st March 2025
(Sharecast News) - Pharma giant AstraZeneca announced on Friday that it is investing $2.5bn in a new global R&D centre in China, along with major research and manufacturing agreements with three of the country's biotech firms.
URL: http://www.digitallook.com/dl/news/story/34959517/...